2023 ESC guidelines for the management of acute coronary syndromes: developed by the task force on the management of acute coronary syndromes of the …

RA Byrne, X Rossello, JJ Coughlan… - … Heart Journal: Acute …, 2024 - academic.oup.com
2023 ESC Guidelines for the management of acute coronary syndromes Page 1 2023 ESC
Guidelines for the management of acute coronary syndromes Developed by the task force on …

Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis

D Adeloye, P Song, Y Zhu, H Campbell… - The Lancet …, 2022 - thelancet.com
Background Chronic obstructive pulmonary disease (COPD) is an increasingly important
cause of morbidity, disability, and mortality worldwide. We aimed to estimate global …

The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial

AA Voors, CE Angermann, JR Teerlink, SP Collins… - Nature medicine, 2022 - nature.com
The sodium–glucose cotransporter 2 inhibitor empagliflozin reduces the risk of
cardiovascular death or heart failure hospitalization in patients with chronic heart failure, but …

Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

GBD Collaborators, VL Feigin, BA Stark… - The Lancet …, 2021 - escholarship.org
BackgroundRegularly updated data on stroke and its pathological types, including data on
their incidence, prevalence, mortality, disability, risk factors, and epidemiological trends, are …

Neutrophils in chronic inflammatory diseases

A Herrero-Cervera, O Soehnlein… - Cellular & molecular …, 2022 - nature.com
Chronic inflammation is a component of many disease conditions that affect a large group of
individuals worldwide. Chronic inflammation is characterized by persistent, low-grade …

Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

VL Feigin, BA Stark, CO Johnson, GA Roth… - The Lancet …, 2021 - thelancet.com
Background Regularly updated data on stroke and its pathological types, including data on
their incidence, prevalence, mortality, disability, risk factors, and epidemiological trends, are …

Epidemiology of cardiovascular disease in Europe

N Townsend, D Kazakiewicz, F Lucy Wright… - Nature Reviews …, 2022 - nature.com
This Review presents data describing the health burden of cardiovascular disease (CVD)
within and across the WHO European Region. CVD remains the most common cause of …

A multi-ancestry polygenic risk score improves risk prediction for coronary artery disease

AP Patel, M Wang, Y Ruan, S Koyama, SL Clarke… - Nature Medicine, 2023 - nature.com
Identification of individuals at highest risk of coronary artery disease (CAD)—ideally before
onset—remains an important public health need. Prior studies have developed genome …

Recent Insights into Particulate Matter (PM2.5)-Mediated Toxicity in Humans: An Overview

P Thangavel, D Park, YC Lee - International journal of environmental …, 2022 - mdpi.com
Several epidemiologic and toxicological studies have commonly viewed ambient fine
particulate matter (PM2. 5), defined as particles having an aerodynamic diameter of less …

Estimates and projections of the global economic cost of 29 cancers in 204 countries and territories from 2020 to 2050

S Chen, Z Cao, K Prettner, M Kuhn, J Yang… - JAMA …, 2023 - jamanetwork.com
Importance Cancers are a leading cause of mortality, accounting for nearly 10 million annual
deaths worldwide, or 1 in 6 deaths. Cancers also negatively affect countries' economic …